Cargando…

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study

BACKGROUND: In the next 25 years, the epidemiology of cervical cancer in England, UK, will change: human papillomavirus (HPV) screening will be the primary test for cervical cancer. Additionally, the proportion of women screened regularly is decreasing and women who received the HPV vaccine are due...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castanon, Alejandra, Landy, Rebecca, Pesola, Francesca, Windridge, Peter, Sasieni, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier, Ltd 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765529/ https://www.ncbi.nlm.nih.gov/pubmed/29307386 http://dx.doi.org/10.1016/S2468-2667(17)30222-0

Ejemplares similares

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
por: Landy, Rebecca, et al.
Publicado: (2016)

Impact of screening on cervical cancer incidence in England: a time trend analysis
por: Pesola, Francesca, et al.
Publicado: (2019)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
por: Wuntakal, R., et al.
Publicado: (2015)

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
por: Landy, Rebecca, et al.
Publicado: (2017)

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study
por: Castanon, Alejandra, et al.
Publicado: (2014)

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?
por: Castanon, Alejandra, et al.
Publicado: (2018)

COVID-19 disruption to cervical cancer screening in England
por: Castanon, Alejandra, et al.
Publicado: (2022)

Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Cervical cytology and the diagnosis of cervical cancer in older women
por: Landy, Rebecca, et al.
Publicado: (2015)

Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review
por: Lim, Anita WW, et al.
Publicado: (2016)

Trends and projections in adenocarcinoma and squamous cell carcinoma of the oesophagus in England from 1971 to 2037
por: Offman, Judith, et al.
Publicado: (2018)

Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries
por: Castanon, Alejandra, et al.
Publicado: (2017)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Cancer incidence in English children, adolescents and young people: past trends and projections to 2030
por: Pesola, Francesca, et al.
Publicado: (2017)

Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study
por: Castanon, Alejandra, et al.
Publicado: (2012)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

Impact of Barrett oesophagus diagnoses and endoscopies on oesophageal cancer survival in the UK: A cohort study
por: Offman, Judith, et al.
Publicado: (2021)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening
por: Falcaro, Milena, et al.
Publicado: (2023)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Projections of care for older people with dementia in England: 2015 to 2040
por: Wittenberg, Raphael, et al.
Publicado: (2020)

Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study
por: Ahmadi-Abhari, Sara, et al.
Publicado: (2017)

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study
por: Castanon, Alejandra, et al.
Publicado: (2021)

Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study
por: Castanon, Alejandra, et al.
Publicado: (2022)

Estimated Projection of US Cancer Incidence and Death to 2040
por: Rahib, Lola, et al.
Publicado: (2021)

Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years
por: Castanon, A, et al.
Publicado: (2013)

Forecasting the Incidence and Prevalence of Patients with End-Stage Renal Disease in Malaysia up to the Year 2040
por: Bujang, Mohamad Adam, et al.
Publicado: (2017)

Evaluating cytology for the detection of invasive cervical cancer
por: Landy, R., et al.
Publicado: (2015)

A Technological Scenario for a Healthier, More Equitable and Sustainable Europe in 2040: Citizen Perceptions and Policy Implications
por: Xhelili, Arlind, et al.
Publicado: (2019)

Spatial distribution estimation of malaria in northern China and its scenarios in 2020, 2030, 2040 and 2050
por: Song, Yongze, et al.
Publicado: (2016)

Exposure Definition in Case–Control Studies of Cervical Cancer Screening: A Systematic Literature Review
por: Castanon, Alejandra, et al.
Publicado: (2021)

Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040
por: Oddone, Enrico, et al.
Publicado: (2020)

Forecasting disability-adjusted life years for chronic diseases: reference and alternative scenarios of salt intake for 2017–2040 in Japan
por: Nomura, Shuhei, et al.
Publicado: (2020)

The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040
por: Zhang, Yanting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ost9jgvv34j12bi50m28bcl1m0